In 2009, Teva Animal Health Incorporated, the largest U.S. manufacturer of generic animal drugs, was ordered by the FDA to cease operations at its facility in St. Joseph, Missouri. The subsidiary of Israel-based Teva Pharmaceuticals had failed to comply with current Good Manufacturing Practice (cGMP) regulations in its quality control, employee training and manufacturing practices. However, following a$14M FDA Compliance Investment project , the project is slowly winding down, and the plant should resume operations in the first quarter of this year.